retatrutide type 2 diabetes phase 2 weight loss 2024 study sees significant in obesity drug study RETATRUTIDE: A Medication for Diabetes

Adults should not exceed 4,000 mg per day

The mechanism by which homocysteine may increase the risk of vascular disease has been the subject of a great deal of research, but it may involve adverse effects of homocysteine on blood clotting, arterial vasodilation, and thickening of arterial walls (84)

GLP-1 use continues to rise with 12.4% of US consumers now on the weight loss drug, up from 5.8% in 2024, according to a recent white paper by The Hartman Group

Building a GLP-1 Gut Support Protocol Based on the research above, a practical approach for supporting your gut during GLP-1 therapy involves three pillars: multi-strain probiotics, prebiotic fiber, and timing

No head-to-head trial has been published, so speed cannot be compared reliably